Medical Innovation Exchange

GSK pays WuXi $40M, bets $1.5B in biobucks for preclinical anti-cancer bispecific antibodies

https://www.fiercebiotech.com/biotech/gsk-pays-wuxi-40m-bets-15b-biobucks-preclinical-anti-cancer-bispecific-antibodies

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!